Wells Fargo lowered the firm’s price target on Q32 Bio (QTTB) to $15 from $16 and keeps an Equal Weight rating on the shares. While bempi’s ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roche Holding AG (RHHVF – Research Report) ...

Q32 Bio Inc. (NASDAQ:QTTB – Get Free Report) has been assigned an average recommendation of “Hold” from the eight research ...

Earnings Estimate Revisions for Q32 Bio This gene editing company is expected to earn -$5.50 per share for the fiscal year ending December 2024, which represents a year-over-year change of 83.2%. ...

W ALTHAM, Mass. - Q32 Bio Inc. (NASDAQ: QTTB), a clinical-stage biotechnology firm trading at $3.18 with a market cap of $38.55 million, announced a strategic shift to prioritize the development ...

Homology Medicines Inc . (NASDAQ: NASDAQ:FIXX), a genetic medicines company, has announced the approval of a reverse stock split at a ratio of 1-for-18, following a green light... As previously ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Q32 Bio Inc. (QTTB) on Tuesday reported a loss of $14.2 million in its fourth quarter. The Waltham, Massachusetts-based company said it had a loss of $1.16 ...

Q32 Bio (NASDAQ:QTTB – Get Free Report) is expected to be releasing its earnings data before the market opens on Tuesday, March 11th. Analysts expect Q32 Bio to post earnings of ($1.25 ...

WALTHAM, Mass., Feb. 4, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune ...

Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in ...

WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Q32 Bio Inc. (QTTB) on Tuesday reported a loss of $14.2 million in its fourth quarter. The Waltham, Massachusetts-based company said it had a loss ...